Hirakata, Japan

Yoshiji Kubo

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: The Green Cross Corporation, Other. Active years: 1996-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiji Kubo. Retrieved from https://idiyas.com/inventor/yoshiji-kubo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1996-2001

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Yoshiji Kubo

Introduction

Yoshiji Kubo is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of angiogenesis research, holding a total of 3 patents. His work focuses on developing compounds that promote angiogenesis, which is crucial for various medical applications.

Latest Patents

Kubo's latest patents include innovative formulations aimed at enhancing angiogenesis. One of his patents describes an angiogenesis promoter containing a specific compound of the following formula (I). Another patent details an angiogenesis promoter and potentiator that includes a pyridazinone compound of the formula (I). These inventions highlight his commitment to advancing medical science through innovative solutions.

Career Highlights

Throughout his career, Yoshiji Kubo has worked with reputable organizations, including The Green Cross Corporation. His experience in these companies has allowed him to refine his expertise in the field of angiogenesis and contribute to significant advancements in medical research.

Collaborations

Kubo has collaborated with notable individuals in his field, including Hideaki Kido and Kazutaka Hayashi. These partnerships have likely enriched his research and led to further innovations in angiogenesis.

Conclusion

Yoshiji Kubo's contributions to the field of angiogenesis through his patents and collaborations demonstrate his dedication to medical innovation. His work continues to impact the scientific community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…